Dr. Adam Mika Kruszewski, MD

Dr. Kruszewski practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Kruszewski's NPI, 1154850212, was assigned on June 12, 2017. Dr. Kruszewski graduated from University of Maryland School of Medicine in 2017. Dr. Kruszewski holds Pennsylvania license MT213808.

Dr. Kruszewski's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Kruszewski's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Kruszewski is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Kruszewski to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kruszewski practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Kruszewski's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Kruszewski is licensed in Pennsylvania.

CMS data shows 793 Medicare services from Dr. Kruszewski across 9 procedure codes in 2024, for 229 Medicare patients. Medicare paid $49,970 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 229 Medicare patients who saw Dr. Kruszewski in 2024. The largest group is 65 to 74, with 104 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kruszewski's median patient age at 57, with 67% women.

In 2024, Dr. Kruszewski wrote 124 Medicare Part D claims for 43 patients. 90% of them were for generic drugs. CMS names the drug for 35 of them, across 2 drugs with 11 or more claims each, at $282 in total drug cost. In 2023, CMS named 95 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Kruszewski for performance year 2024, reported as part of a group. Dr. Kruszewski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Kruszewski, published from 2015 to 2023. 2015 was the busiest year, with 2. The most frequent topics are Glatiramer Acetate, Multiple Sclerosis and Cell Cycle Proteins. Dr. Kruszewski has published most often in Exp Mol Pathol. Dr. Kruszewski's most frequent co-authors are Violeta Rus, MD, Cosmin Tegla, MD and Cornelia Diana Cudrici, MD.

CMS Open Payments shows 4 general payments to Dr. Kruszewski from 3 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Alexion Pharmaceuticals, Inc. paid the most, $243.

Dr. Kruszewski graduated from University of Maryland School of Medicine in 2017.